Alexion Pharmaceuticals, Inc.
Pharmaceutical firm reports loss of $1.01 per share
Published in Lab Business Week, January 16th, 2005
Alexion reported revenues amounting to $147,000 for the first quarter ended October 31, 2004. This matched revenues of $147,000 reported for the same period last year.
Total operating expenses for the quarter were $22.3 million, compared to $19.5 million for the same quarter last year. The company's research and development expenses for the 3-month period ended October 31, 2004 were $18.7 million compared to $16.7 million for the same period last year.
The $2.0 million increase in research and development expenses...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
Source: Lab Business Week (2005-01-16)
More Articles from Lab Business Week
- Amphora Discovery Corporation
Drug discovery company completes $20M Series C financing - Array BioPharma, Inc.
Biopharma company prices public offering of 8,000,000 shares of common stock - Arrowhead Research Corporation
Company provides additional funding for nanotech research - Bentley Pharmaceuticals, Inc.
Pharmaceutical firm retains investor relations counsel - Biomira, Inc.
Biomira announces U.S. $10 million financing - CABG Medical, Inc.
Device firm announces pricing of public offering - More from this issue of Lab Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
